At the 32nd Annual Meeting of the European Psychiatric Association (EPA), held between 6-9th of April in Budapest, Hungary, new analyses of cariprazine studies were presented by Gedeon Richter Plc. The scientific posters provided evidence that cariprazine might be an appropriate treatment not only for early and late-stage schizophrenia, but also for the difficult-to-treat dual disorder (schizophrenia and comorbid substance use disorder), which is a major problem for psychiatrists to manage. Furthermore, on the 7th of April with the support of Professor Christoph U. Correll, a new transdiagnostic tool for quantifying, and visualizing symptom severity and functional disability of patients with different psychiatric conditions was presented. In addition, on the 8th of April, a special Gedeon Richter publication, the “Candid Book” was also presented by the authors, which contains useful, everyday solutions and suggestions for the caregivers of schizophrenia patients.